Maisons du Monde S.A. (EPA:MDM)

Oncternal Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.3	90.5	29.89	121.26	163.23	296.74
Cash & Short-Term Investments	96.3	90.5	29.89	121.26	163.23	296.74
Cash Growth	297.36%	202.82%	-75.35%	-25.71%	-44.99%	214.04%
Accounts Receivable	2.84	9.29	10.1	12.3	10.48	12.44
Other Receivables	27.16	34.02	59.78	51.88	40.32	36.27
Receivables	30	43.31	69.88	64.17	50.8	48.71
Inventory	223.88	199.74	202.15	245.73	193.75	171.53
Prepaid Expenses	24.02	19.51	20.33	23.8	22.55	19.86
Other Current Assets	0.93	9.45	1.41	13.74	58.43	48.66
Total Current Assets	375.14	362.51	323.65	468.7	488.76	585.48
Property, Plant & Equipment	580.06	654.62	726.73	790.5	763.18	788.17
Long-Term Investments	12.74	13.03	13.85	16.45	17.03	15.82
Goodwill	246.03	246.03	327.03	327.03	327.03	327.03
Other Intangible Assets	245.39	248.36	247.12	238.91	232.68	243.13
Long-Term Deferred Tax Assets	7.96	8.01	8.74	9.77	8.59	6.31
Other Long-Term Assets	-	0.58	0.09	1.62	6.38	2.55
Total Assets	1,467	1,533	1,647	1,853	1,844	1,968
Accounts Payable	149.36	160.19	138.97	156.64	102.44	102.03
Accrued Expenses	50.33	59.87	70.13	88.74	85.75	67.4
Short-Term Debt	0.02	0.04	4.81	0.12	0.03	0.01
Current Portion of Long-Term Debt	226.09	121.28	30.35	223.79	29.23	200.08
Current Portion of Leases	104.85	109.4	121.02	118.97	110.6	111.94
Current Income Taxes Payable	6.23	5.35	2.93	3.53	0.92	2.6
Current Unearned Revenue	37.11	40.58	52.67	66.99	96.99	83.33
Other Current Liabilities	21.32	7.26	21.89	16.83	10.69	25.72
Total Current Liabilities	595.32	503.96	442.78	675.61	436.64	593.11
Long-Term Debt	26.83	53.87	83.95	0.27	192.33	188.47
Long-Term Leases	388.35	411.76	450	494.17	483.64	508.13
Long-Term Deferred Tax Liabilities	17.69	33.95	39.17	46.29	52.31	41.74
Other Long-Term Liabilities	26.04	19.34	25.68	23.31	13.9	30.93
Total Liabilities	1,065	1,034	1,051	1,249	1,191	1,374
Common Stock	126.97	126.97	126.97	140.25	146.58	146.58
Additional Paid-In Capital	73.8	73.8	73.8	102.73	134.28	134.28
Retained Earnings	-75.56	-115.35	8.57	34.3	77.37	1.48
Comprehensive Income & Other	276.44	413.28	385.69	325.63	292.89	310.05
Total Common Equity	401.65	498.71	595.03	602.91	651.13	592.4
Minority Interest	0.7	0.76	1.38	1.18	1.24	2.32
Shareholders' Equity	402.36	499.46	596.41	604.09	652.37	594.72
Total Liabilities & Equity	1,467	1,533	1,647	1,853	1,844	1,968
Total Debt	746.13	696.34	690.13	837.32	815.83	1,009
Net Cash (Debt)	-649.83	-605.84	-660.24	-716.06	-652.6	-711.89
Net Cash Per Share	-16.92	-15.71	-16.20	-15.01	-13.12	-15.82
Filing Date Shares Outstanding	38.51	38.57	38.58	40.56	44.42	45.01
Total Common Shares Outstanding	38.51	38.57	38.58	40.56	44.42	45.01
Working Capital	-220.18	-141.45	-119.13	-206.91	52.12	-7.62
Book Value Per Share	10.43	12.93	15.42	14.86	14.66	13.16
Tangible Book Value	-89.76	4.32	20.88	36.98	91.42	22.25
Tangible Book Value Per Share	-2.33	0.11	0.54	0.91	2.06	0.49

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.